Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China
-
Published:2021-06-09
Issue:1
Volume:16
Page:
-
ISSN:1748-717X
-
Container-title:Radiation Oncology
-
language:en
-
Short-container-title:Radiat Oncol
Author:
Chang Xiao, Deng Wei, Wang Xin, Zhou Zongmei, Yang Jun, Guo Wenling, Liu Miaoling, Qi Xiaolu, Li Ling, Zhang Kaixian, Zhang Min, Shi Yonggang, Liu Ke, Zhao Yidian, Wang Huitao, Yu Zhilong, Zhang Jihong, Wang Lihua, Qiao Xueying, Han Chun, Zhu Shuchai, Zhang Ruohui, Chen Junqiang, Hu Cairong, Zhang Fuquan, Hou Xiaorong, Pang Qingsong, Zhang Wencheng, Li Gaofeng, Lin Hailei, Sun Xinchen, Ge Xiaolin, Li Caihong, Ge Hong, Li Dingjie, Wang Yadi, Lu Na, Gao Xianshu, Qin Shangbin, Tian Yuan, Xiao ZefenORCID
Abstract
Abstract
Purpose
To investigate the interobserver variability (IOV) in target volume delineation of definitive radiotherapy for thoracic esophageal cancer (TEC) among cancer centers in China, and ultimately improve contouring consistency as much as possible to lay the foundation for multi-center prospective studies.
Methods
Sixteen cancer centers throughout China participated in this study. In Phase 1, three suitable cases with upper, middle, and lower TEC were chosen, and participants were asked to contour a group of gross tumor volume (GTV-T), nodal gross tumor volume (GTV-N) and clinical target volume (CTV) for each case based on their routine experience. In Phase 2, the same clinicians were instructed to follow a contouring protocol to re-contour another group of target volume. The variation of the target volume was analyzed and quantified using dice similarity coefficient (DSC).
Results
Sixteen clinicians provided routine volumes, whereas ten provided both routine and protocol volumes for each case. The IOV of routine GTV-N was the most striking in all cases, with the smallest DSC of 0.37 (95% CI 0.32–0.42), followed by CTV, whereas GTV-T showed high consistency. After following the protocol, the smallest DSC of GTV-N was improved to 0.64 (95% CI 0.45–0.83, P = 0.005) but the DSC of GTV-T and CTV remained constant in most cases.
Conclusion
Variability in target volume delineation was observed, but it could be significantly reduced and controlled using mandatory interventions.
Funder
the Beijing Hope Run Special Fund of Cancer Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,Oncology
Reference37 articles.
1. Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA, Al-Sarraf M, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85–01). J Am Med Assoc. 1999;281:1623–7. 2. Chang JY, Gomez DR, Allen PK, Younes AI, Bhutani M, Komaki RU, et al. Local control and toxicity of a simultaneous integrated boost for dose escalation in locally advanced esophageal cancer: interim results from a prospective phase I/II trial. J Thorac Oncol. 2016;12:375–82. 3. Welsh J, Palmer MB, Ajani JA, Liao Z, Swisher SG, Hofstetter WL, et al. Esophageal cancer dose escalation using a simultaneous integrated boost technique. Int J Radiat Oncol Biol Phys. 2012;82:468–74. 4. Tai P, Van Dyk J, Yu E, Battista J, Stitt L, Coad T. Variability of target volume delineation in cervical esophageal cancer. Int J Radiat Oncol Biol Phys. 1998;42:277–88. 5. Tai P, Van Dyk J, Battista J, Yu E, Stitt L, Tonita J, et al. Improving the consistency in cervical esophageal target volume definition by special training. Int J Radiat Oncol Biol Phys. 2002;53:766–74.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|